Oncologia

Roche Holding saw its shares drop significantly following the failure of its phase 3 persevERA trial for the breast cancer drug giredestrant to meet its primary endpoint. Despite the setback, the company remains optimistic about the drug's potential in other indications. Analysts view the result as a non-existential hurdle for Roche's broader portfolio.

19 febbraio 2026 Riportato dall'IA

La Corte Suprema Federale (Stf) ha approvato all’unanimità un accordo interfederativo che ridefinisce il finanziamento dei farmaci oncologici nel Sistema Unico di Salute (Sus). La decisione stabilisce regole per il rimborso da parte dell’Unione e determina la competenza giudiziaria per le azioni relative a questi trattamenti. L’accordo segue la creazione di una nuova politica di assistenza farmaceutica oncologica.

Clínica Medilaser in Neiva, Huila, is establishing itself as a regional reference center for comprehensive blood cancer management. Led by Dr. Álvaro Eduardo Mondragón Cardona, the institution provides advanced treatments combining chemotherapy and immunotherapy. This allows patients from southern Colombia to receive specialized care without traveling elsewhere.

30 ottobre 2025 Riportato dall'IA

Patients at Port Elizabeth Provincial Hospital in Nelson Mandela Bay are facing renewed shortages of essential chemotherapy drugs, leaving pediatric oncology cases vulnerable. The Eastern Cape Department of Health attributes the issue to a suspended account with a key supplier, with negotiations ongoing to restore supply. This marks the third major stockout this year, highlighting persistent procurement challenges.

A new study showed quantum technology achieving 80% tumor shrinkage in brain cancer, published in The Lancet Oncology on September 11, 2025.

11 settembre 2025 Riportato dall'IA

Summit's new drug for lung cancer demonstrated promising results in recent assessments. This development is part of ongoing biotech advancements in oncology. It was reported alongside other health innovations.